---
title: "Eden launches world's first compounded semaglutide gummy, offering GLP-1 benefits without needles."
description: "In Denver on December 31, 2024, Eden unveiled the global debut of the first compounded semaglutide gummy. This gummy, available at tryeden.com, is crafted to provide the advantages of GLP-1 drugs in a"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/223690536.md"
published_at: "2024-12-31T16:11:22.000Z"
---

# Eden launches world's first compounded semaglutide gummy, offering GLP-1 benefits without needles.

> In Denver on December 31, 2024, Eden unveiled the global debut of the first compounded semaglutide gummy. This gummy, available at tryeden.com, is crafted to provide the advantages of GLP-1 drugs in a user-friendly, needle-free form. This groundbreaking product transforms the way people engage with GLP-1 therapies.

In Denver on December 31, 2024, Eden unveiled the global debut of the first compounded semaglutide gummy. This gummy, available at tryeden.com, is crafted to provide the advantages of GLP-1 drugs in a user-friendly, needle-free form. This groundbreaking product transforms the way people engage with GLP-1 therapies.

### Related Stocks

- [NVO.US - Novo Nordisk AS](https://longbridge.com/en/quote/NVO.US.md)
- [EDEN.US - ISHRS MSCI Denmark Capped Invt](https://longbridge.com/en/quote/EDEN.US.md)
- [600867.CN - THDB](https://longbridge.com/en/quote/600867.CN.md)
- [300199.CN - HYBIO](https://longbridge.com/en/quote/300199.CN.md)
- [LLY.US - Eli Lilly](https://longbridge.com/en/quote/LLY.US.md)
- [AZN.US - AstraZeneca](https://longbridge.com/en/quote/AZN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Puzo Michael J 在诺和诺德公司 $NVO 拥有价值 32 万美元的股票持仓 | Puzo Michael J 在第三季度大幅减持了 Novo Nordisk A/S (NYSE:NVO) 的股份，减少幅度达到 86.9%，目前持有 5,775 股，价值 320,000 美元。其他机构投资者也调整了他们的持仓，True  | [Link](https://longbridge.com/en/news/276447697.md) |
| 诺和诺德公司董事会提议再次选举 Lars Rebien Sorensen 担任主席 | 诺和诺德公司董事会提议重新选举拉斯·瑞比恩·索伦森为董事长 | [Link](https://longbridge.com/en/news/276440991.md) |
| 特朗普暗示违法征收的关税不退了，美财长称今年关税收入将 “基本保持不变” | 美国总统特朗普暗示不会退还被最高法院裁定违法的关税，预计 2026 年关税收入将保持不变。特朗普计划签署行政令，对全球商品加征 10% 进口关税，取代被推翻的关税。财长贝森特表示，政府将利用替代法律权力维持关税收入，强调国家安全和财政收入不 | [Link](https://longbridge.com/en/news/276494362.md) |
| 最高法裁决后特朗普动用替补选择：加征 10% 全球关税 | 美国总统特朗普在最高法院裁决后宣布将加征 10% 的全球关税，以补救被推翻的关税措施。根据《1974 年贸易法》第 122 条款，现有的关税将全面生效。最高法院裁定特朗普政府的部分关税措施缺乏法律授权。市场风险提示，投资需谨慎。 | [Link](https://longbridge.com/en/news/276477629.md) |
| 高盛：诺和诺德定价压力被市场过度定价，口服 Wegovy 将是扭转信心的关键 | 高盛称，当前股价已完全消化 2026 财年最悲观预期。市场低估了 Medicare 放开的销量潜力和口服版 Wegovy 的收入前景。口服 Wegovy 上市表现强劲，已开出 5 万张处方，其中 9 成为自费需求，显示刚性市场潜力，将成为扭 | [Link](https://longbridge.com/en/news/275095024.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.